OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active ...

OAKLAND, Calif., Oct. 24, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...

Koya Medical has shared data highlighting that its non-pneumatic compression device (NPCD) demonstrated better efficacy and improved quality of life in patients with lower extremity lymphedema. The ...

Interim clinical trial data presented at American Vein and Lymphatic Society Annual Congress demonstrate patient preference, strong therapy adherence, improved quality-of-life measures, and reduction ...

OAKLAND, Calif. , May 26, 2021 /PRNewswire/ -- Koya Medical , a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that it has ...

OAKLAND, Calif. and TAMPA, Fla., March 6, 2024 /PRNewswire/ -- Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized ...

Andy Doraiswamy (CEO) and Damian Rippole (CFO) will highlight the company's commercial momentum for its portfolio—including Dayspring® non-pneumatic compression treatment for chronic edema—and share ...

OAKLAND, Calif., Jan. 14, 2021 /PRNewswire/ -- Koya Medical (www.koyamedical.com), a healthcare company focused on treating lymphedema and vein disease, today announced the close of a $11 million ...

OAKLAND, Calif., May 20, 2021 /PRNewswire/ -- Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, will present at the Oppenheimer ...

OAKLAND, Calif., Dec. 27, 2022 /PRNewswire/ -- Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...